Play the "combo fist" in the diagnosis and treatment of advanced gastric cancer
10.3760/cma.j.cn441530-20231215-00221
- VernacularTitle:打好晚期胃癌诊疗“组合拳”
- Author:
Lei LIAN
1
;
Shi YIN
;
Jian XIAO
;
Junsheng PENG
Author Information
1. 中山大学附属第六医院普通外科（胃外科），广州 510655
- Keywords:
Stomach neoplasms,advanced;
Distant metastasis;
Diagnosis;
Laparoscopic exploration;
Conversion therapy;
Heterogeneity
- From:
Chinese Journal of Gastrointestinal Surgery
2024;27(2):196-204
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of gastric cancer ranks fifth among malignant tumors worldwide, with the fourth highest mortality rate. A noteworthy characteristic of our country is the high prevalence of advanced-stage patients of approximately 40%. Advanced-stage gastric cancer carries an unfavorable prognosis with median survival of around one year. Diagnosis methods for advanced-stage gastric cancer (such as laparoscopic exploration, molecular profiling, and artificial intelligence) are still being continuously improved, while chemotherapy remains the primary treatment. With the rapid development of medical science, the role of surgical intervention in advanced-stage gastric cancer is becoming increasingly prominent. Therefore, as gastric tumor surgeons, we should consider how to use a combination of treatments, including surgery, chemotherapy, targeted therapy, immunotherapy, and interventional therapy, based on different pathological stages and the heterogeneity of tumors. With a multidisciplinary approach involving experts from various fields, we can collectively improve the survival rate and quality of life for advanced-stage patients. This article provides a brief overview of the current advances in the diagnosis and treatment of advanced-stage gastric cancer, and discusses therapeutic decision primarily from the perspective of surgeons.
